DGAP-PVR: RHÃ?N-KLINIKUM AG: Release according to Article

RH�N-KLINIKUM AG 17.10.2013 09:03 Dissemination of a Voting Rights Announcement, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Notification according to section 26 para. 1 WpHG B. Braun Holding GmbH & Co. KG, Melsungen, Germany, BraHo Verwaltungsgesellschaft mbH, Melsungen, Germany, Ludwig G. Braun GmbH & Co. KG, Melsungen, Germany, Prof. Dr. h.c. Ludwig Georg Braun, Germany, Martin Lüdicke, Germany, and Ilona Braun, Germany, notified us pursuant to section 25a para. 1 WpHG of the following: 1) On 14 October 2013, B. Braun Holding GmbH & Co. KG exceeded the threshold of 5% and 10% of the voting rights in RH�N-KLINIKUM Aktiengesellschaft, Schlossplatz 1, 97616 Bad Neustadt a. d. Saale, Germany. On that date, B. Braun Holding GmbH & Co. KG held 10.98% of the voting rights in RH�N-KLINIKUM Aktiengesellschaft arising from 15,173,376 voting rights. From these voting rights a proportion of 10.98% (equals 15,171,376 voting rights) is based on voting rights pursuant to sections 21, 22 WpHG and a proportion of 0.001% (equals 1,000 voting rights) is based on (financial / other) instruments pursuant to section 25 WpHG. From the voting rights based on instruments pursuant to section 25 WpHG a proportion of 0.001% (equals 1,000 voting rights) is held indirectly. In addition, a proportion of 0.001% (equals 1,000 voting rights) is based on (financial/other) instruments pursuant to section 25a WpHG. From the voting rights based on instruments pursuant to section 25a WpHG a proportion of 0.001% (equals 1,000 voting rights) is held indirectly. The instruments pursuant to section 25a WpHG are sold put options ('Verkaufte Put-Optionen') with expiration date 22 December 2014 (chain of controlled undertakings: B. Braun Melsungen Aktiengesellschaft). 2) On 14 October 2013, BraHo Verwaltungsgesellschaft mbH exceeded the threshold of 5% and 10% of the voting rights in RH�N-KLINIKUM Aktiengesellschaft, Schlossplatz 1, 97616 Bad Neustadt a. d. Saale, Germany. On that date, B. Braun Holding GmbH & Co. KG held 10.98% of the voting rights in RH�N-KLINIKUM Aktiengesellschaft arising from 15,173,376 voting rights. From these voting rights a proportion of 10.98% (equals 15,171,376 voting rights) is based on voting rights pursuant to sections 21, 22 WpHG and a proportion of 0.001% (equals 1,000 voting rights) is based on (financial / other) instruments pursuant to section 25 WpHG. From the voting rights based on instruments pursuant to section 25 WpHG a proportion of 0.001% (equals 1,000 voting rights) is held indirectly. In addition, a proportion of 0.001% (equals 1,000 voting rights) is based on (financial/other) instruments pursuant to section 25a WpHG. From the voting rights based on instruments pursuant to section 25a WpHG a proportion of 0.001% (equals 1,000 voting rights) is held indirectly. The instruments pursuant to section 25a WpHG are sold put options ('Verkaufte Put-Optionen') with expiration date 22 December 2014 (chain of controlled undertakings: B. Braun Holding GmbH & Co. KG, B. Braun Melsungen Aktiengesellschaft). 3) On 14 October 2013, Ludwig G. Braun GmbH & Co. KG exceeded the threshold of 5% and 10% of the voting rights in RH�N-KLINIKUM Aktiengesellschaft, Schlossplatz 1, 97616 Bad Neustadt a. d. Saale, Germany. On that date, B. Braun Holding GmbH & Co. KG held 10.98% of the voting rights in RH�N-KLINIKUM Aktiengesellschaft arising from 15,173,376 voting rights. From these voting rights a proportion of 10.98% (equals 15,171,376 voting rights) is based on voting rights pursuant to sections 21, 22 WpHG and a proportion of 0.001% (equals 1,000 voting rights) is based on (financial / other) instruments pursuant to section 25 WpHG. From the voting rights based on instruments pursuant to section 25 WpHG a proportion of 0.001% (equals 1,000 voting rights) is held indirectly. In addition, a proportion of 0.001% (equals 1,000 voting rights) is based on (financial/other) instruments pursuant to section 25a WpHG. From the voting rights based on instruments pursuant to section 25a WpHG a proportion of 0.001% (equals 1,000 voting rights) is held indirectly. The instruments pursuant to section 25a WpHG are sold put options ('Verkaufte Put-Optionen') with expiration date 22 December 2014 (chain of controlled undertakings: B. Braun Holding GmbH & Co. KG, B. Braun Melsungen Aktiengesellschaft). 4) On 14 October 2013, Prof. Dr. h.c. Ludwig Georg Braun exceeded the threshold of 5% and 10% of the voting rights in RH�N-KLINIKUM Aktiengesellschaft, Schlossplatz 1, 97616 Bad Neustadt a. d. Saale, Germany. On that date, B. Braun Holding GmbH & Co. KG held 10.98% of the voting rights in RH�N-KLINIKUM Aktiengesellschaft arising from 15,173,376 voting rights. From these voting rights a proportion of 10.98% (equals 15,171,376 voting rights) is based on voting rights pursuant to sections 21, 22 WpHG and a proportion of 0.001% (equals 1,000 voting rights) is based on (financial / other) instruments pursuant to section 25 WpHG. From the voting rights based on instruments pursuant to section 25 WpHG a proportion of 0.001% (equals 1,000 voting rights) is held indirectly. In addition, a proportion of 0.001% (equals 1,000 voting rights) is based on (financial/other) instruments pursuant to section 25a WpHG. From the voting rights based on instruments pursuant to section 25a WpHG a proportion of 0.001% (equals 1,000 voting rights) is held indirectly. The instruments pursuant to section 25a WpHG are sold put options ('Verkaufte Put-Optionen') with expiration date 22 December 2014 (chain of controlled undertakings: Ludwig G. Braun GmbH & Co. KG, B. Braun Holding GmbH & Co. KG, B. Braun Melsungen Aktiengesellschaft). 5) On 14 October 2013, Martin Lüdicke exceeded the threshold of 5% and 10% of the voting rights in RH�N-KLINIKUM Aktiengesellschaft, Schlossplatz 1, 97616 Bad Neustadt a. d. Saale, Germany. On that date, B. Braun Holding GmbH & Co. KG held 10.98% of the voting rights in RH�N-KLINIKUM Aktiengesellschaft arising from 15,173,376 voting rights. From these voting rights a proportion of 10.98% (equals 15,171,376 voting rights) is based on voting rights pursuant to sections 21, 22 WpHG and a proportion of 0.001% (equals 1,000 voting rights) is based on (financial / other) instruments pursuant to section 25 WpHG. From the voting rights based on instruments pursuant to section 25 WpHG a proportion of 0.001% (equals 1,000 voting rights) is held indirectly. In addition, a proportion of 0.001% (equals 1,000 voting rights) is based on (financial/other) instruments pursuant to section 25a WpHG. From the voting rights based on instruments pursuant to section 25a WpHG a proportion of 0.001% (equals 1,000 voting rights) is held indirectly. The instruments pursuant to section 25a WpHG are sold put options ('Verkaufte Put-Optionen') with expiration date 22 December 2014 (chain of controlled undertakings: BraHo Verwaltungsgesellschaft mbH, B. Braun Holding GmbH & Co. KG, B. Braun Melsungen Aktiengesellschaft). 6) On 14 October 2013, Ilona Braun exceeded the threshold of 5% and 10% of the voting rights in RH�N-KLINIKUM Aktiengesellschaft, Schlossplatz 1, 97616 Bad Neustadt a. d. Saale, Germany. On that date, B. Braun Holding GmbH & Co. KG held 10.98% of the voting rights in RH�N-KLINIKUM Aktiengesellschaft arising from 15,173,376 voting rights. From these voting rights a proportion of 10.98% (equals 15,171,376 voting rights) is based on voting rights pursuant to sections 21, 22 WpHG and a proportion of 0.001% (equals 1,000 voting rights) is based on (financial / other) instruments pursuant to section 25 WpHG. From the voting rights based on instruments pursuant to section 25 WpHG a proportion of 0.001% (equals 1,000 voting rights) is held indirectly. In addition, a proportion of 0.001% (equals 1,000 voting rights) is based on (financial/other) instruments pursuant to section 25a WpHG. From the voting rights based on instruments pursuant to section 25a WpHG a proportion of 0.001% (equals 1,000 voting rights) is held indirectly. The instruments pursuant to section 25a WpHG are sold put options ('Verkaufte Put-Optionen') with expiration date 22 December 2014 (chain of controlled undertakings: BraHo Verwaltungsgesellschaft mbH, B. Braun Holding GmbH & Co. KG, B. Braun Melsungen Aktiengesellschaft). Bad Neustadt a.d. Saale, 17 October 2013 The Board of Management ________________________________________________________________ Dr. Kai G. Klinger Head of Investor Relations RH�N-KLINIKUM AG Schlossplatz 1 97616 Bad Neustadt a. d. Saale Phone: +49 9771 65 - 1318 Fax: +49 9771 99 - 1736 17.10.2013 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: RH�N-KLINIKUM AG Schlossplatz 1 97616 Bad Neustadt a.d.Saale Germany Internet: www.rhoen-klinikum-ag.com End of Announcement DGAP News-Service ---------------------------------------------------------------------------